Gamma-vinyl-GABA potentiates the severity of naloxone-precipitated abstinence signs in morphine-dependent rats

Pharmacological Research

Volumn 38, Issue 1, 1998, Pages 45-51

  Sayin, Ümit ^a,b   Atasoy, Sevil ^c   Uzbay, I Tayfun ^d   Aricioǧlu Kartal, Feyza ^e   Koyuncuoǧlu, Hikmet ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c ISTANBUL UNIVERSITY   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

^e Department of Pharmacology   (Turkey)

Author keywords

GABA; Gamma vinyl GABA (GVG); Inhibition; Morphine abstinence syndrome; Morphine physical dependence; Vigabatrin

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; MORPHINE; NALOXONE; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DEFECATION; DIARRHEA; DISEASE SEVERITY; ENZYME INHIBITION; EXTRACELLULAR SPACE; INTRAPERITONEAL DRUG ADMINISTRATION; JUMPING; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; PTOSIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOM; TREATMENT FAILURE; WET DOG SHAKES; WITHDRAWAL SYNDROME;

EID: 0032125552     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0329     Document Type: Article

References (42)

1. 1. Stolerman I. Drugs of abuse: behavioral principals, methods and terms. TIPS 1992; 13: 170-6.
2. 2. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. TIPS 1992; 13: 177-84.
3. 3. Olson GA, Olson RD, Kastin AJ. Endogenous opiates: 1993. Peptides 1994; 15: 1513-56.
4. 4. Trujillo KA, Akil H. Inhibition of opiate tolerance by non-competitive antagonists. Brain Res 1994; 633: 178-88.
5. 5. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991; 261: 85-6.
6. 6. Tanganelli S, Antonelli T, Morari M, Bianchi C, and Beani L. L-Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci Lett 122: 270-2.
7. 7. Koyuncuoǧlu H, Sayin Ü, Dizdar Y, Aricioglu F. Effects of competitive NMDA receptor blocker CGP 39551 on morphine physical dependence. Tr J Med Sci 1994; 21: 163-8.
8. 8. Koyuncuoǧlu H, Dizdar Y, Aricioglu F, Sayin Ü. Effects of MK-801 on morphine physical dependence: attenuation and intensification. Pharm Biochem Behav 1992; 43: 487-90.
9. 9. Popik P, Skolnick P. The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol Biochem Behav 1996; 53: 791-7.
10. 10. Foote F, Gale K. Proconvulsant effect of morphine on seizures induced by pentylenetetrazol in the rat. Eur J Pharmacol 1984; 105: 179-84.
11. 11. Gale K. GABA in epilepsy: pharmacological basis. Epilepsia 1989; 30 (Suppl 3): S1-S11.
12. 12. Suzuki T, Tsuda M, Narita M, Funada M, Mizoguchi H, Misawa M. Diazepam pretreatment suppresses morphine withdrawal signs. Life Sci 1995; 58: 349-57.
13. 14C]-GABA from rat brain synaptosomes. Life Sci 1996; 58: 447-54.
14. 14. Raman AF, Takahashi M, Kaneto H. Role of GABAergic systems in the development of morphine tolerance in formalin-treated mice. Japan J Pharmacol 1995; 68: 207-11.
15. 15. Halonen T, Pitkanen A, Riekkinen PJ. Administration of vigabatrin affects the levels of inhibitory and excitatory amino acids in rat cerebrospinal fluid. J Neurochem 1990; 55: 1870-3.
16. 16. Hammond EJ, Wilder BJ. Gamma Vinyl GABA. Gen Pharmacol 1985; 16: 441-7.
17. 17. Sayin Ü, Timmerman W, Westerink BHC. The significance of extracellular GABA in the substantia nigra of the rat during seizures and anticonvulsant treatment. Brain Res 1995; 669: 67-72.
18. 18. Iodorala MJ, Gale K. Substantia nigra: site of anticonvulsant activity mediated by GABA antagonists. Science 1982; 218: 1237-40.
19. 19. Kendal DA, Fox DA, Enna SJ. Effect of GVG on bicuculline induced seizures. Neuropharmacology 1981; 20: 351-5.
20. 20. Sayin Ü, Cengiz S, Altug T. Vigabatrin as an anticonvulsant against pentylenetetrazol seizures. Pharmacol Res 1993; 28: 325-31.
21. 21. Stevens J, Philips I, Beuropaire R. Gamma vinyl GABA in endopiriform area suppresses kindled amygdala seizures. Epilepsia 1988; 29: 404-11.
22. 22. Sayin Ü, Purali N, Özkan T, Altug T, Buyukdevrim S. Vigabatrin has an anxiolytic effect in the elevated plus maze test of anxiety. Pharmacol Biochem Behav 1992; 43: 529-35.
23. 23. Koyuncuoǧlu H, Saydam B. The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan with chlorpromazine. Int J Clin Pharmacol Ther and Toxicol 1990; 28: 147-52.
24. 24. Blaesig J, Herz A, Reinhold K, Zielgaensberger S. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated abstinence syndrome in rats. Psychopharmacologia 1973; 33: 19-38.
25. 25. Way EL, Loh HH, Shen F. Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 1969; 167: 1-8.
26. 26. Aricioglu-Kartal F, Uzbay IT. Inhibitory effect of agmantine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci 1997; 61: 1775-81.
27. 27. Aghajanian GK, Kogan JH, Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res 1994; 636: 126-30.
28. 28. Lope F, Miller LG, Thompson ML, Schatzki A, Chesley S, Greenblatt DJ, Shader RI. Chronic morphine administration augments benzodiazepine binding and GABA-A receptor function. Psychopharmacology 1990; 101: 545-9.
29. 29. Klitenick MA, DeWitte P, Kalivas PW. Regulation of somatodentritic dopamine release in the ventral tegmental area by opiates and GABA: an in vivo microdialysis study. J Neurosci 1992; 12: 2623-32.
30. 30. Renno WM, Mullet MA, Beitz AJ. Systemic morphine reduces GABA release in the lateral but not in the medial portion of the midbrain periaquaductal gray of the rat. Brain Res 1992; 594: 221-32.
31. 31. Beani L, Bianchi C, Ferraro L, Morari M, Simonato M, Spatullo G, Tanganelli S. Alpha-2-adrenoceptor-mediated decreases in GABA outflow in cortical slices and synaptosomes during morphine tolerance. J Pharmacol Exp Ther 1991; 258: 472-6.
32. 32. Antonelli T, Beani L, Bianchi C, Rando S, Simonato M, Tanganelli S. Cortical acetylcholine release is increased and GABA outflow is reduced during morphine withdrawal. Br J Pharmacol 1986; 89: 853-60.
33. 33. Baldino F, Cowan A, Geller EB, Adler M. The effects of antipsychotic and antianxiety drugs on the morphine abstinence syndrome in rats. J Pharmacol Exp Ther 1979; 208: 63-6.
34. 34. Wang FS, Fujimoto JM. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice. J Pharmacol Exp Ther 1993; 265: 1361-8.
35. 35. Contreras E, Tamayo L, Quijada L. The effects of the irreversible inhibition of GABA transaminase upon some morphine effects. Neuropharmacology 1979; 18: 309-13.
36. 36. Jackson M, Trevor D, Esplin B, Capek R. Acute effects of gamma-vinyl-GABA on hippocampal inhibition in vitro. Brain Res 1994; 651: 85-91.
37. 37. Sayin Ü, Rutecki PA, Mellanby J, Sutula T. GammaVinyl-GABA impairs paired pulse inhibition in the rat dentate gyrus in vivo and in vitro. Epilepsia 1997; 38 (S8): 110-11.
38. 38. Loiseau P, Hardenberg JP, Pester M, Guyot M, Schechter P, ell GP. Double blind placebo controlled study of vigabatrin in drug resistant epilepsy. Epilepsia 1986; 27: 115-20.
39. 39. Reynolds EG, Ring H, Heller A. A controlled trial of gamma vinyl GABA in drug resistant epilepsy. Br J Clin Pharmacol 1988; 33: 937-46.
40. 40. Luna D, Dulac O, Pajot N, Beaumont D. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo controlled study. Epilepsia 1989; 30: 430-7.
41. 41. de Krom MC, Verduin N, Visser E, Kleijer M, Scholtes F, De Groen JH. Status epilepticus during vigabatrin treatment: a report of three cases. Seizure 1995; 2: 159-62.
42. 42. Dean P, Gale K. Anticonvulsant action of GABA receptor blockade in the nigrotectal target region. Brain Res 1989; 477: 391-5.